Karen S. Lynch - 01 Apr 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: President and CEO, Director
Signature: /s/ Karen S. Lynch
Issuer symbol: CVS
Transactions as of: 01 Apr 2024
Net transactions value: +$13,635,152
Form type: 4
Filing time: 03 Apr 2024, 16:47:56 UTC
Previous filing: 14 Feb 2024
Next filing: 21 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock (Restricted)	Award	$3,599,931	+45,248		$79.56	45,248	01 Apr 2024	Direct	F1
transaction	CVS	Common Stock	Tax liability	$4,928,981	-61,953	-45%	$79.56	74,687	01 Apr 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Award	$14,964,202	+188,087		$79.56	188,087	01 Apr 2024	Common Stock	188,087	$79.56	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal annual installments, commencing 4/1/2025.
F2	Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units.
F3	Option becomes exercisable in four equal annual installments, commencing 4/1/2025.